9999999997-18-006949.txt : 20180724
9999999997-18-006949.hdr.sgml : 20180724
20180717122309
ACCESSION NUMBER: 9999999997-18-006949
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20180724
DATE AS OF CHANGE: 20180717
ACTION DATE: 20180724
RECEIVED DATE: 20180717
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001422142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53057
FILM NUMBER: 18956010
BUSINESS ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
BUSINESS PHONE: (513) 985-1920
MAIL ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP II
DATE OF NAME CHANGE: 20071227
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR
M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T
M:" V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G (.1@94 .*S,' T((LQ
M0S$#0R,#-P/[)T>82JZ%4!UM8%T,DD$0/B,[0( ! (^%!"(-"F5N9'-T7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
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M.4FU][B+'3=K71J(AXSJT*5GQTV5X4F#K& LR^2P:3*
M-[/4X8FIM5GOR+RJ"Y4[TY,O2=J*OAF59^MQNMC&(#,/0>UH$O7Q<% F'^I?H47?BX_T>VA>ZG;I(+F/?
MB]6Q[05MKM)(M)Y80] BQQ=7UQ)2G!.2RH\1\DTNAJ]P,>;74?&C+.3T&A:>
M!">"Z_\\/&>=U]W$^PQTO&LYA,SJ9NVRV/GW.>4Q]/:G2[Z=!-F#.?O:,:FM
MJ<\]Y/3EG])EYSW,,9YV'/PGP !@QHE0#0IE;F1S=')E86T-96YD;V)J#3$T
M(# @;V)J#3P\+T9I;'1EJL+@2K8NU;XYC9YUMG,)6@ ))4<@2';-0
M)*]$-9N_[_ BWQ*D+U40F:3(,Y=S9OCE9NW#\3_-U>MU0,!)_Q[X8W!]ZH>07MN5]%<[<$IY
M?J*.V\'KX)$\+!?IS'$#FI!K6#MN2&.2.M0GD]2LSNPB.'^FMP,WHG$#N %@LKP&-#*B$?EC^FVRO+$3F-[?W2W6Z\7]TL#'
M-(F/X K25]BN'6',MUWY!BP8 O,P39;I8WJ!SR[GVRFC,+P/"#6YUU93+_-H,\6YFEFLP.3:0KW<_"3D4H^(X$%1"*"3R+U_7-V
M/DK@A#=[429%G93N$1953#1)1QCZQ@9QZP8GDYJ+DL*PI>&XX
M\D*D#Z;S7T91$ 5Z/XU/)$C^^NC1^U#\@1&_2IN-(CBJVCL/*SJ$944'CLOB
MT#N+SQFC_DZ"=$(E.AUIVVU>#+DQ]9@A5Z&->EQ_I&,64O("L@JR_;Y$%"GJ
M"KJJX VL.HR5UM1\$J*K 39\$PJ
M?T>$.RZ66R5A6S<@*GR;=31M'![3".$.'H][&U99Z)^0P'_F95>@Z]NF5N?WRPIM<#9'$K=#%BMN396 /CF([ZC7C6XA)+H<0P@-=TRF%,&1/9//D/)'@R1EJY&OQ
MST%;?1Z/K#V25J&@Q6G=[.O&@,Z%J6@FED'AU'1S[?B6^2YW538!65;\.CU&VQX"5"
MLKYQA_Y'I:)&"D='L.??0$X+)':S_?NWA*8M^QYS814RP:39YHE>"&JM1[=5H%]B)-_".IAQ[K
MQ\:9#U0ZQ*0W;9=56GBF6VN43Z_* @E\SG3_[^2N;H1\^]I'] $/[P=]EC0=
M^%QA;B-&&I5B)1/U@^Q6:MDC4LU5#8&9WZIY@,5.S5PS$Y*YFOFX+/K]!Z!2
M#1@."G.B5?-$M8M>/H>K4VLE.&@%GS7/&RZSYLW,E,P4#!7,+10L+'1]RO-+8X&<0T4@F+M[( BP?HN=G8 08 C84(
M-PT*96YDFMC.60B/SX*/'@Z
M>&UP;65T82!X;6QN#IX;7!T:STB061O
M8F4@6$U0($-O"UN&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!D9B\Q+C,O(@H@(" @(" @(" @("!X;6QN&UP.D-R96%T941A=&4^,C Q."TP
M-RTQ-U0Q,CHR,3HP.2TP-#HP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @
M(#QX;7 Z0W)E871O&UP34TZ26YS=&%N8V5)
M1#YU=6ED.F1E.&%E,V1A+3,Q-68M-#DV,BUB8V,V+34P83DQ,3,X-6,V.#PO
M>&UP34TZ26YS=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(#POJ'5!:DZ@?,RQ"L(P$(#A5[G-
M9#!-8JVME()8#L_G]_!1KJ.MM-_$02!Z17/W0R
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M0S4R-S1#-T8U,3X\1D8U03
MB-4+(MB!$L]6 %D,#(Q @ND_D&!D @P 'BU!1L-"F5N9'-T